Sources
Story Timeline
•Latest version
Liraglutide and Ozempic-Style Drugs May Soon Be Approved for Young Children
Experts Call for Intervention as Child Obesity Rises, Debate Over Ozempic, Liraglutide, and Mounjaro
•Original version
Experts Urge Action on Child Obesity; Novo Nordisk Prepares for Price Negotiations on GLP-1 Drugs
